Company profile: Base Life Science
1.1 - Company Overview
Company description
- Provider of information technology consulting and solutions, including the BASE Migration Framework for complex, compliant data migrations; Veeva Development Cloud services for process strategy, implementation, training, and post-implementation support; clinical process optimization, system training and implementation (CDMS, eTMF, CTMS); and CRO onboarding and oversight.
Products and services
- Clinical Systems Implementation: Delivers a process-driven service that architects and streamlines processes for implementing clinical systems like CDMS, eTMF, and CTMS, ensuring successful implementation
- BASE Migration Framework: Produces an enterprise-grade software system that manages complex data migrations, ensuring compliance and efficiency in transitioning data systems
- Veeva Development Cloud: Offers a compliance-focused service comprising business process and strategy support, implementation, training, and post-implementation support for Veeva systems
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Base Life Science
Apicore
HQ: United States
Website
- Description: Provider of process R&D and active pharmaceutical ingredient (API) manufacturing services for the pharmaceutical industry worldwide, specializing in difficult-to-synthesize, high-value, and niche specialty APIs, serving customers in the generic medicine industry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Apicore company profile →
Clinilabs
HQ: United States
Website
- Description: Provider of clinical drug development services specializing in CNS medications, from first-in-human to Phase 3 trials. Offers global site selection via a network in 42 countries, decentralized trials using telemedicine, electronic tools, remote assessment and wearables, corelab data services to centralize and improve data accuracy, and centralized PSG and EEG capture and analysis for clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinilabs company profile →
Aquila BioMedical
HQ: United Kingdom
Website
- Description: Provider of pre-clinical contract research services with expertise in immuno-oncology, immunology, and multiplex histology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aquila BioMedical company profile →
CoreRx
HQ: United States
Website
- Description: Provider of contract pharmaceutical drug product development services to pharma and biotech, delivering cGMP solutions for dosage form development. Offerings include preformulation, formulation, analytical and stability services, GMP manufacturing and packaging, modified-release dosage forms, and oral solids (tablets and capsules) including immediate and controlled release.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CoreRx company profile →
PackGene
HQ: United States
Website
- Description: Provider of CRO/CDMO services for gene and cell therapy, specializing in AAV vectors, mRNA, plasmid DNA, and lentiviral solutions. Offerings include AAV vector design and construction; small- to large-scale AAV production up to GMP; π-Icosa serotype screening; Express Gene-to-AAV from synthesis to packaging; and on-demand gene editing mRNAs (e.g., Cas9). Supports discovery, preclinical, and trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PackGene company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Base Life Science
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Base Life Science
2.2 - Growth funds investing in similar companies to Base Life Science
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Base Life Science
4.2 - Public trading comparable groups for Base Life Science
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →